CoChat

Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members

Gratacòs, Elena, Pérez‐Navarro, Esther, Tolosa, Eduard, Arenas, Ernest, Alberch, Jordi · 2001 · Journal of Neurochemistry
Cited by 83

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Neurotrophic factors are regarded as potential therapeutic tools in neurodegenerative disorders. Here, we analysed the protective effects of brain‐derived neurotrophic factor, neurotrophin‐3, glial cell line‐derived neurotrophic factor and neurturin against the excitotoxic damage induced by kainate in striatal neurons in vitro and in vivo. Our results show that the decrease in the number of cultured striatal calbindin‐positive neurons induced by kainate was prevented by treatment with any of these factors. To characterize their protective effects in vivo, cell lines overexpressing brain‐derived neurotrophic factor, neurotrophin‐3, glial cell line‐derived neurotrophic factor or neurturin were grafted into the striatum. We found that the numbers of striatal projection neurons (calbindin‐positive) and striatal interneurons (parvalbumin‐ or choline acetyltransferase‐positive) were differentially decreased after kainate lesion. These neurotrophic factors prevented the loss of striatal projection neurons and interneurons with differing efficiency: brain‐derived neurotrophic factor was the most efficient, whereas neurturin was the least. Our findings show that brain‐derived neurotrophic factor, neurotrophin‐3, glial cell line‐derived neurotrophic factor and neurturin have specific neuroprotective profiles in striatal neurons and indicate that they are specific modulators of the survival of distinct subsets of striatal neurons in pathophysiological conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2001.00538.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Estimation of nuclear population from microtome sections

    Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363 · cited 1×

    “Cell counts were corrected using the Abercrombie method (Abercrombie 1946) and then converted to the number of cells per mm2 by dividing them by the area of each ®eld (0.061 mm2 for calbindin-positive neurons; 0.246 mm2 for parvalbumin-positive neurons and 1.52 mm2 for ChAT-positive neurons).”
    MethodInfluential
  • Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

    Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · cited 1×

    “…effects within the basal ganglia in several models of neurotoxicity, e.g. 6-hydroxydopamine (Sauer et al. 1995; Horger et al. 1998; AÊ kerud et al. 1999), MPTP (Spina et al. 1992; Frim et al. 1994; Tomac et al. 1995; Gash et al. 1996) and axotomy-induced degeneration (Beck et al. 1995; Hagg 1998).”
    Background
  • Functional recovery in parkinsonian monkeys treated with GDNF

    Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955 · cited 1×

    “…effects within the basal ganglia in several models of neurotoxicity, e.g. 6-hydroxydopamine (Sauer et al. 1995; Horger et al. 1998; AÊ kerud et al. 1999), MPTP (Spina et al. 1992; Frim et al. 1994; Tomac et al. 1995; Gash et al. 1996) and axotomy-induced degeneration (Beck et al. 1995; Hagg 1998).”
    Background
  • Alternative excitotoxic hypotheses

    Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · cited 1×

    “…death, is responsible for many neurological disorders ranging from acute insults, such as stroke, hypoglycemia and epilepsy, to chronic neurodegenerative diseases, such as Huntington's disease or amyotrophic lateral sclerosis (for a review see Albin and Greenamyre 1992; Lipton and Rosenberg 1994).”
    Background
  • Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat

    Frim, D. M., Uhler, T. A., Galpern, W. R., Beal, M. F., Breakefield, X. O., & Isacson, O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5104 · Cited by 269 · cited 1×

    “…effects within the basal ganglia in several models of neurotoxicity, e.g. 6-hydroxydopamine (Sauer et al. 1995; Horger et al. 1998; AÊ kerud et al. 1999), MPTP (Spina et al. 1992; Frim et al. 1994; Tomac et al. 1995; Gash et al. 1996) and axotomy-induced degeneration (Beck et al. 1995; Hagg 1998).”
    Background

Cited by

See all 83

Metadata

Authors
Gratacòs, E., Pérez‐Navarro, E., Tolosa, E., Arenas, E., & Alberch, J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2001-09-15
Volume
78
Issue
6
Pages
1287-1296
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1479712018
Cited by
83
References
5
FWCI
2.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.